Interact to see
Advertisement
Advertisement
JMKCX vs MEDFX
JMKCX vs MEDFX Comparison
Open Charts JMKCX vs MEDFX
JHancock Emerging Markets Debt C
Price$8.03
Change-$0.01 (-0.12%)
VolumeN/A
Net Assets1.16B
MFS Emerging Markets Debt R3
Price$12.54
Change-$0.01 (-0.08%)
VolumeN/A
Net Assets7.55B
JMKCX vs MEDFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
JMKCX vs. MEDFX commentary
Oct 07, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMKCX is a Hold and MEDFX is a Hold.
FUNDAMENTALS
Fundamentals
MEDFX has more cash in the bank: 7.55B vs. JMKCX (1.16B). MEDFX (5.26) and JMKCX (5.00) have matching dividends . JMKCX was incepted earlier than MEDFX: JMKCX (11 years) vs MEDFX (17 years). JMKCX (1.89) is less costly to investors than MEDFX (1.07). MEDFX is a more actively managed with annual turnover of: 58.00 vs. JMKCX (38.00). MEDFX has a lower initial minimum investment than JMKCX: MEDFX (0) vs JMKCX (1000). MEDFX annual gain was more profitable for investors over the last year : 7.55 vs. JMKCX (6.72). JMKCX (12.43) and MEDFX (12.34) have equivalent 5 years return.
| JMKCX | MEDFX | JMKCX / MEDFX | |
| Total Expense Ratio | 1.88 | 1.06 | 177% |
| Annual Report Gross Expense Ratio | 1.89 | 1.07 | 177% |
| Fund Existence | 11 years | 17 years | - |
| Gain YTD | 8.038 | 8.993 | 89% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.16B | 7.55B | 15% |
| Annual Yield % from dividends | 5.00 | 5.26 | 95% |
| Returns for 1 year | 6.72 | 7.55 | 89% |
| Returns for 3 years | 37.66 | 39.03 | 97% |
| Returns for 5 years | 12.43 | 12.34 | 101% |
| Returns for 10 years | 42.13 | 45.42 | 93% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement